Get 40% Off
👀 👁 🧿 All eyes on Biogen, up +4,56% after posting earnings. Our AI picked it in March 2024.
Which stocks will surge next?
Unlock AI-picked Stocks

Brazil sees dealmaking boom led by energy, retail, healthcare

Published 07/02/2021, 10:12 AM
Updated 07/02/2021, 10:17 AM
© Reuters. FILE PHOTO: A placard shows prices for ethanol and gasoline at a gas station in Cuiaba, Brazil October 2, 2019. REUTERS/Marcelo Teixeira

By Carolina Mandl and Tatiana Bautzer

SAO PAULO (Reuters) - Brazilian companies are striking mammoth share offerings and M&A deals, as Latin America's biggest economy recovers from the COVID pandemic with expected full-year GDP growth of 5%, potentially further lifting sectors from energy to healthcare.

M&A volume grew eightfold in the first half of 2021 from the same period a year earlier, to $56.8 billion, while share offerings totaled $15.3 billion, up 55%.

Bankers expect activity to remain buoyant during the second half, boosted by an optimistic economic outlook, with sectors such as retail and fintechs in the spotlight.

In the first half, healthcare operator Hapvida's $9.58 billion acquisition of Notre Dame Intermedica was the seventh largest deal in emerging markets, while state-controlled oil company Petrobras' $6.45 billion acquisition of deepwater oil fields Atapu and Sepia fields ranked thirteenth.

The privatization of Rio de Janeiro state water and sewage utility Cedae raised roughly $4 billion, luring Singapore's GIC, Canadian pension fund CPPIB and local holding company Itausa.

"There is a virtuous circle in place for deals: economic activity is picking up, benchmark interest rates are low and money is available," said Eduardo Miras, Brazil head of investment banking at Citi.

Brazil's largest share offering this year happened on the last day of June, with the sale of Petrobras' stake in fuel distributor Petrobras Distribuidora SA. Petroleo Brasileiro SA, as the seller is formally known, raised 11.36 billion reais ($2.3 billion).

Companies such as energy firm Raizen, a joint venture between Cosan (NYSE:CZZ) SA and Royal Dutch Shell (LON:RDSa) Plc, cement maker Intercement Brasil SA and oncology clinics chain Oncoclinicas plan to price multibillion-real IPOs in the coming weeks.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

These deals are expected to lure deep-pocketed foreign investors, who shunned Brazilian share offerings earlier this year amid snowballing pandemic and political turmoil, taking the place of domestic investors who have grown more cautious.

"Foreign investors are no longer as worried about the pandemic as the pace of vaccination has picked up over the last few weeks," said Roderick Greenlees, head of investment banking at Itau BBA, which led the equities league table in the first half. He predicted share offerings will reach 160 billion reais this year, a 33% rise from 2020.

Foreign investors spent 65.1 million reais buying Brazilian companies' shares, net of outflows, in the first semester, according to stock exchange operator B3, compared with a net outflow of 62.8 billion reais in the year-ago period.

Still, domestic investors have grown more timid, as benchmark interest rates have risen to 4.25% from 2% in January. Equity funds have gotten 1.7 billion reais in net new money this year through May, dwarfed by net inflows of 94.1 billion reais for fixed income funds.

DEALS CYCLE

Strong capital markets activity is also increasing funds available for acquisitions, said Bruno Amaral, head of M&A at Banco BTG Pactual, which led the Brazil M&A league table in the first half.

Hard hit industries during the pandemic such as retail have been among the most active in deals in recent months as Brazil recovers and consumption rises, Amaral said.

"We are also seeing a lot of deals in the financial area, mainly fintechs taking on the large banks, and in healthcare," he added.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Warren Buffett's Berkshire Hathaway (NYSE:BRKa) Inc led a $750 million funding round in fast-growing fintech Nubank, while private equity firm Advent International invested $430 million in payments company Ebanx.

Below, the Brazil league tables for M&A advisory and ECM bookrunning during the first half

M&A - Brazilian Target (NYSE:TGT) Announced

Financial adviser Deals value ($ million) Number of deals

Banco BTG Pactual 20,962 31

JPMorgan (NYSE:JPM) 19,837 8

Itau Unibanco 17,009 18

BR Partners 15,235 8

Citi 14,499 7

XP (NASDAQ:XP) Investimentos 10,013 5

Santander (MC:SAN) 8,894 13

Banco Bradesco 8,823 17

BofA 6,934 4

Rothschild 6,725 10

TOTAL 57,295 494

Source - Refinitiv Deals Intelligence

ECM - Global Equity and Related - Brazil

Book Runner Proceeds ($ million) Number of issues

Itau Unibanco 2,622 34

Banco BTG Pactual 1,764 31

Morgan Stanley (NYSE:MS) 1,383 16

BofA Securities 1,274 13

XP Investimentos 1,217 18

JPMorgan 1,198 14

Santander 1,074 15

Banco Bradesco 1,057 17

Citi 914 11

Goldman Sachs (NYSE:GS) 858 8

TOTAL 15,336 46

Source - Refinitiv Deals Intelligence

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.